Welcome to NHVMAS

welcome

The New HIV Vaccine and Microbicide Advocacy Society (formerly Nigeria HIV Vaccine and Microbicides Advocacy Group (NHVMAG)) was born out of a collective vision of a few Nigerian activists to ensure proactive and early involvement of the Nigerian Government and its citizens in New HIV Prevention Technology research and development.NHVMAS is a popularly owned campaign, with its members, supporters and partners as the driving force. It was established in 2003 as a broad movement of vaccine and microbicides advocates. It resulted from outcomes of collaborative meetings held around the drafting of Nigeria's National Vaccine Plan in 2001/2002; Networking among advocates after microbicide conferences in USA (2001), Belgium (2002) and advocates meeting at Microbicides 2004 in London (25 Nigerian advocates in attendance). This resulted in the first National Advocates Meeting in Abuja in May 2004. Read More

News

International Women’s day: THE GENDER AGENDA: GAINING MOMENTUM

NHVMAS Statement on the VOICE Study Result

Nigeria: a haven for clinical trials

Community calls for improved ethical practices in research

Cure for HIV: A prize to keep our eyes on

Rethinking the risk factors for sexual risk among young persons: the evidence from analysis of South Africa and the USA

The need to discuss a rectal microbicide agenda for Nigeria

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study

Use of injectible hormonal contraceptives and risk of HIV-1 transmission

End of project report: Building capacity of laypersons to communicate NPT trial results

A simpler tool for estimation of HIV incidence from cross-sectional, age-specific prevalence data

Age related HIV incidence among sex workers

HIV incidence data for FSW in Nassarawa - Report from Biotech Initative, Nigeria

Treating HIV-infected People with Antiretrovirals Protects HIV-negative Partners from Infection

Adaptive Clinical Trials Design - Part II

Adaptive Trial Design 1: An Overview

Perceptive survey highlights growing interest in adaptive trial designs

Workshop on Interpreting and communicating biomedical HIV prevention research trial results

One antiretroviral pill a day may keep HIV infection away: call for action NHVMAS outlines potential next steps for the Nigerian Community

Understanding Combination Prevention: the way forward for effective HIV prevention

Cure for HIV infection must now be major scientific priority, Vienna AIDS conference hears

NHVMAS statement on CAPRISA 004

NHVMAS statement on MDP 301 result:

NHVMAS celebrates its 7th Anniversary with funfare!!!!

A Brief History of New HIV Prevention Research

NHVMAS at ICASA 2008

New HIV Prevention Technology research: the Nigeria story

Update on the aborted HIV Vaccine trial -

Future access to Microbicides

Advocates in Nigeria disappointed with the Carraguard study result and advocates for continued research efforts on Microbicide

Roundtable proffers ways of respecting the rights of participants in

No associations between the use of Lemon Juice douching and other STI

Different types of Microbicides

Glossary of terms used in microbicides research

M2008:Do you understand the language of Microbicides research

New lessons on HIV infection route

The diaphragm: A Female-initiated barrier methods

HSV-2 suppression: efforts at preventing HIV infection

Post exposure Prophylaxis (PeP)

New HIV Prevention technology pipelines - ARV treatment of index partners

New HIV prevention technology pipelines - the story of PreP

New HIV Prevention Technologies - HIV Vaccines

Prevention of Mother to Child Transmission (PMTCT)

Interpreting the results of HIV prevention trials (2)

Interpreting the results of HIV prevention trials (3) - So far so...

Could vaginal microbicides protect men more so than women?

HSV-2 treatment does not reduce the risk of HIV infection.

Identified risk factor for HIV infection in women

When microbicide clinical trials end: lessons learnt and role of advocates

SAVVY trial result dissemination efforts in Lagos, Nigeria

NHVMAS members make it to the IRMA Board

The thrill about the HPTN 035 study

What would the face of HIV control be in the next 25 years?

Total Visitors:25751

The New HIV Vaccine and Microbicide Advocacy Society was born out of a collective vision of a few Nigerian activists to ensure proactive and early involvement of the Nigerian Government and its citizens in New HIV Prevention Technology research and development. Read More...

A Nigeria where new biomedical HIV prevention and reproductive health tools are readily accessible to its citizens Strategic vision: A strengthened NHVMAS that is strategically position to address NPT and reproductive health related issues as defined in the national HIV/AIDS response. Read More...

The New HIV Vaccine and Microbicide Advocacy Society works with communities through its partner organisations and individuals to facilitate research literacy. Updating and information sharing is a key strategy of NHVMAS in achieve this goal. It therefore ensures all its members are enlisted on its mailing list for the NHVMAS ECHOES and subscription to its list-serve.